{"disease":{"id":"vaso-occlusive-pain-episode-in-sickle-cell-disease","name":"vaso occlusive pain episode in sickle cell disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05348915","title":"A Study to Evaluate the Long-term Safety of Inclacumab Administered to Participants With Sickle Cell Disease","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":242,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04935879","title":"A Study to Assess the Safety and Efficacy of Inclacumab in Participants With Sickle Cell Disease Experiencing Vaso-occlusive Crises","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":241,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT07369024","title":"Sub-dissociative Dose Ketamine in Treatment of Vaso-occlusive Pain Event in Children and Young Adults","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Mohsen Saidinejad","has_results":false},{"nct_id":"NCT07274254","title":"Lidocaine for Opioid Sparing in Vaso-occlusive Crisis of Sickle Cell Disease","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":104,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04927247","title":"A Study of a Single Dose of Inclacumab to Reduce Re-admission in Participants With Sickle Cell Disease and Recurrent Vaso-occlusive Crises","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":72,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT05848531","title":"Clonidine With Morphine in Patient Controlled Analgesia Pump in Vaso-Occlusive Crisis in Sickle Cell Disease Patient","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":40,"lead_sponsor_name":"Centre Hospitalier Universitaire Saint Pierre","has_results":false},{"nct_id":"NCT06184126","title":"Virtual Reality Devices as an Adjunct to Usual Care for Patients With Sickle Cell Disease Experiencing Vaso-Occlusive Crises","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT04150757","title":"Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Abigail Nixon","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}